AMVUTTRA® is dosed 4 times per year via subcutaneous injection1
- The recommended dose of AMVUTTRA is 25 mg administered by subcutaneous injection once every 3 months by a healthcare professional.1
(See section 2.2 of full Prescribing Information for complete Administration Instructions.) - AMVUTTRA is provided as a fixed dose (25 mg/0.5 mL) prefilled syringe—no dose adjustments are recommended.1
- If a dose is missed, administer AMVUTTRA as soon as possible. Resume dosing every 3 months from the most recently administered dose.1
- Home administration may be an option for some patients. The decision for a patient to receive treatment at home should be made after an evaluation and recommendation by the treating physician and may not be covered by all insurance plans.
Premedication and laboratory monitoring are not required for AMVUTTRA.

Learn more about dosing and administration.